Who owns Stoke Therapeutics Inc?
- Ticker: STOK
- CUSIP Number: 86150r107
Tip: Access positions for across all investors
Analyze quarterly positions in Stoke Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Stoke Therapeutics stock
Who bought or sold Stoke Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Skorpios Trust | 14M | $195M | 0% | Mar 2024 |
|
| Redmile Group | 5.1M | $69M | 93% | Mar 2024 |
|
| Morgan Stanley | 4.0M | $54M | 38% | Mar 2024 |
|
| BlackRock | 3.9M | $52M | 75% | Mar 2024 |
|
| Lynx1 Capital Management | 3.7M | $50M | 25% | Mar 2024 |
|
| Baker Bros. Advisors | 3.4M | $46M | 66% | Mar 2024 |
|
| Cowen And Company | 3.4M | $45M | -10% | Mar 2024 |
|
| Vanguard Group | 1.7M | $23M | 4% | Mar 2024 |
|
| Goldman Sachs Group | 1.4M | $19M | 1% | Mar 2024 |
|
| Franklin Resources | 1.1M | $14M | 100% | Mar 2024 |
|
| Geode Capital Management | 640k | $8.6M | 8% | Mar 2024 |
|
| Granahan Investment Management | 476k | $6.4M | -44% | Mar 2024 |
|
| Cormorant Asset Management | 427k | $5.8M | -61% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 412k | $5.6M | 0% | Mar 2024 |
|
| FMR | 376k | $5.1M | 9972% | Mar 2024 |
|
| Artal Group | 300k | $4.1M | 100% | Mar 2024 |
|
| Northern Trust | 261k | $3.5M | -2% | Mar 2024 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 239k | $1.3M | 0% | Dec 2023 |
|
| Sio Capital Management | 226k | $3.0M | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 223k | $3.0M | 9% | Mar 2024 |
|
| Dimensional Fund Advisors | 220k | $3.0M | 2% | Mar 2024 |
|
| D. E. Shaw & Co | 194k | $2.6M | 36% | Mar 2024 |
|
| Marshall Wace | 179k | $2.4M | 100% | Mar 2024 |
|
| DAFNA Capital Management | 145k | $2.0M | 100% | Mar 2024 |
|
| Point72 Asset Management | 143k | $1.9M | 100% | Mar 2024 |
|
| Palo Alto Investors | 126k | $1.7M | 100% | Mar 2024 |
|
| Nuveen Asset Management | 120k | $1.6M | 91% | Mar 2024 |
|
| Woodline Partners | 107k | $1.4M | 88% | Mar 2024 |
|
| Maven Securities | 100k | $1.4M | 100% | Mar 2024 |
|
| Laurion Capital Management | 100k | $1.4M | 100% | Mar 2024 |
|
| Susquehanna International | 100k | $1.3M | 38% | Mar 2024 |
|
| Citadel Advisors | 99k | $1.3M | 480% | Mar 2024 |
|
| GSA Capital Partners | 98k | $1.3M | -5% | Mar 2024 |
|
| Mirae Asset Global Investments | 91k | $728k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 90k | $1.2M | -9% | Mar 2024 |
|
| Fort Point Capital Partners | 75k | $397k | 0% | Dec 2023 |
|
| Monashee Investment Management | 68k | $912k | 100% | Mar 2024 |
|
| Thomas Stevens, CFA" | 62k | $841k | 0% | Mar 2024 |
|
| Gilder, Gagnon, Howe & Co | 62k | $327k | 0% | Dec 2023 |
|
| Squarepoint Ops | 51k | $690k | 168% | Mar 2024 |
|
| LMR Partners | 50k | $675k | 100% | Mar 2024 |
|
| State of Wisconsin Investment Board | 48k | $651k | -44% | Mar 2024 |
|
| Jacobs Levy Equity Management | 48k | $647k | -71% | Mar 2024 |
|
| Millennium Management | 46k | $621k | 92% | Mar 2024 |
|
| Eudaimonia Asset Management | 46k | $619k | 100% | Mar 2024 |
|
| Susquehanna Portfolio Strategies | 43k | $586k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 42k | $565k | 2% | Mar 2024 |
|
| Gts Securities | 42k | $562k | 100% | Mar 2024 |
|
| Trexquant Investment | 40k | $209k | -69% | Dec 2023 |
|
| UBS Group | 39k | $532k | 32% | Mar 2024 |
|
| Alliancebernstein | 37k | $196k | -10% | Dec 2023 |
|
| Belvedere Trading | 34k | $452k | 100% | Mar 2024 |
|
| Tudor Investment Corporation | 33k | $450k | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 31k | $425k | 6% | Mar 2024 |
|
| Seven Grand Managers | 30k | $405k | 100% | Mar 2024 |
|
| American Century Companies | 30k | $400k | 84% | Mar 2024 |
|
| Bank of America Corporation | 29k | $386k | -62% | Mar 2024 |
|
| Zacks Investment Management | 21k | $289k | 52% | Mar 2024 |
|
| PDT Partners | 21k | $289k | 100% | Mar 2024 |
|
| Chase Investment Counsel Corp. | 21k | $279k | 100% | Mar 2024 |
|
| Barclays | 21k | $278k | -47% | Mar 2024 |
|
| Hudson Bay Capital Management | 20k | $270k | 100% | Mar 2024 |
|
| Bridgeway Capital Management | 17k | $231k | 100% | Mar 2024 |
|
| XTX Topco | 16k | $220k | 100% | Mar 2024 |
|
| Two Sigma Investments | 16k | $209k | 38% | Mar 2024 |
|
| MetLife Investment Advisors | 15k | $77k | 0% | Dec 2023 |
|
| Jane Street | 14k | $194k | -72% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 14k | $194k | 86% | Mar 2024 |
|
| American International | 14k | $72k | 0% | Dec 2023 |
|
| Algert Coldiron Investors | 13k | $66k | -24% | Dec 2023 |
|
| Jpmorgan Chase & Co | 11k | $148k | -40% | Mar 2024 |
|
| Dorsey & Whitney Trust Company | 11k | $146k | 0% | Mar 2024 |
|
| New York State Common Retirement Fund | 11k | $143k | -1% | Mar 2024 |
|
| Florida State Board of Administration | 11k | $87k | 100% | Mar 2024 |
|
| Principal Financial Group | 11k | $141k | -13% | Mar 2024 |
|
| Wells Fargo & Company | 9.9k | $133k | 16% | Mar 2024 |
|
| SG Americas Securities | 9.7k | $130k | -36% | Mar 2024 |
|
| Aquatic Capital Management | 9.6k | $130k | 100% | Mar 2024 |
|
| Ikarian Capital | 6.8k | $92k | -44% | Mar 2024 |
|
| Lazard Asset Management | 5.8k | $0 | 4% | Dec 2023 |
|
| Citigroup | 5.5k | $77k | 38% | Mar 2024 |
|
| Cutler | 3.3k | $1.2k | 200% | Mar 2024 |
|
| ADAR1 Capital Management | 2.9k | $39k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 2.8k | $38k | -88% | Mar 2024 |
|
| Tower Research Capital | 2.7k | $36k | -29% | Mar 2024 |
|
| Summit Investment Advisors | 2.3k | $31k | 0% | Mar 2024 |
|
| Legal & General Group | 2.3k | $31k | -27% | Mar 2024 |
|
| NISA Investment Advisors | 2.0k | $26k | 1% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.5k | $8.0k | 0% | Dec 2023 |
|
| Simplex Trading | 1.2k | $15k | -86% | Mar 2024 |
|
| Royal Bank of Canada | 1.1k | $14k | -86% | Mar 2024 |
|
| Amalgamated Bank | 787.00 | $11k | -63% | Mar 2024 |
|
| Stone House Investment Management | 500.00 | $6.8k | 100% | Mar 2024 |
|
| Provence Wealth Management Group | 470.00 | $2.5k | 0% | Dec 2023 |
|
| GAMMA Investing | 117.00 | $1.6k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 61.00 | $822.999800 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 5.00 | $67.000000 | 100% | Mar 2024 |
|
| Pnc Financial Services | 5.00 | $68.000000 | 0% | Mar 2024 |
|
Who sold out of Stoke Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wellington Management Company | Sep 2023 | 174k | $687k |
| Ameriprise Financial | Sep 2023 | 33k | $130k |
| ALPS Advisors | Sep 2023 | 33k | $129k |
| Ohio Pers | Dec 2023 | 17k | $91k |
| Man Group | Dec 2023 | 15k | $81k |
| Verition Fund Management | Sep 2023 | 15k | $60k |
| Ing Investment Management | Sep 2023 | 11k | $44k |
| Two Sigma Advisers | Dec 2023 | 11k | $58k |
| Boothbay Fund Management | Sep 2023 | 10k | $39k |
| Federated Investors | Sep 2023 | 1.1k | $4.2k |